Back to ESLA

Estrella Immunopharma, Inc. 8-K

Accession 0001575872-23-000296

Filing information

CIK
0001844417
Report date
2023-02-17
Filing date
2023-02-21
Form
8-K
Primary document
uptd-20230123.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.